New SU2C-Lustgarten Foundation team aims to apply CAR T-cell therapy to pancreatic cancer – EurekAlert (press release)
|
New SU2C-Lustgarten Foundation team aims to apply CAR T-cell therapy to pancreatic cancer
EurekAlert (press release) The approach is called chimeric antigen receptor (CAR) T-cell therapy, which uses specially modified immune cells to find and destroy cancerous cells. A version of CAR T-cell therapy was recently endorsed by an advisory committee to the Food and Drug … |
